Drug Registration and Acceptance

Drug Name

Exact

Active Ingredient

Acceptance No.

Manufacturers

Acceptance Date

Status Date

Classification

Review Status

Drug Type

Submission

Evaluation Conclusion

ATC Category

Special Approval Varieties

Task Type

Major Special Varieties

Sequence No.

Stock Code

Visualized Analysis Export Evaluation Conclusion Evaluation Progress

Acceptance No.	Drug Name	Active Ingredient	Dosage Form	Classification	Submission	Acceptance Date	Manufacturers	View
JXSS2400091	纳武利尤单抗注射液	nivolumab	Injection	Biological Products(3.1)	Import Drug Application	2024-10-13	Bristol-Myers Squibb Pharma Eeig;Bristol-Myers Squibb Holdings Pharma Ltd Liability Company;BRISTOL-MYERS Squibb (CHINA) Co Ltd	view
JXSS2400090	纳武利尤单抗注射液	nivolumab	Injection	Biological Products(3.1)	Import Drug Application	2024-10-13	Bristol-Myers Squibb Pharma Eeig;Bristol-Myers Squibb Holdings Pharma Ltd Liability Company;BRISTOL-MYERS Squibb (CHINA) Co Ltd	view
JXSS2400062	纳武利尤单抗注射液	nivolumab	Injection	Biological Products(2.2)	Import Drug Application	2024-07-19	Bristol-Myers Squibb Pharma Eeig;Bristol-Myers Squibb Holdings Pharma Ltd Liability Company;BRISTOL-MYERS Squibb (CHINA) Co Ltd	view
JXSS2400061	纳武利尤单抗注射液	nivolumab	Injection	Biological Products(2.2)	Import Drug Application	2024-07-19	Bristol-Myers Squibb Pharma Eeig;Bristol-Myers Squibb Holdings Pharma Ltd Liability Company;BRISTOL-MYERS Squibb (CHINA) Co Ltd	view
JXSS2400059	纳武利尤单抗注射液	nivolumab	Injection	Biological Products(2.2)	Import Drug Application	2024-07-17	Bristol-Myers Squibb Pharma Eeig;Bristol-Myers Squibb Holdings Pharma Ltd Liability Company;BRISTOL-MYERS Squibb (CHINA) Co Ltd	view
JXSS2400058	纳武利尤单抗注射液	nivolumab	Injection	Biological Products(2.2)	Import Drug Application	2024-07-17	Bristol-Myers Squibb Pharma Eeig;Bristol-Myers Squibb Holdings Pharma Ltd Liability Company;BRISTOL-MYERS Squibb (CHINA) Co Ltd	view
JXSS2400037	纳武利尤单抗注射液	nivolumab	Injection	Biological Products(2.2)	Import Drug Application	2024-04-18	Bristol-Myers Squibb Pharma Eeig;Bristol-Myers Squibb Holdings Pharma Ltd Liability Company;BRISTOL-MYERS Squibb (CHINA) Co Ltd	view
JXSS2400039	纳武利尤单抗注射液	nivolumab	Injection	Biological Products(2.2)	Import Drug Application	2024-04-18	Bristol-Myers Squibb Pharma Eeig;Bristol-Myers Squibb Holdings Pharma Ltd Liability Company;BRISTOL-MYERS Squibb (CHINA) Co Ltd	view
JXSS2400015	纳武利尤单抗注射液	nivolumab	Injection	Biological Products(2.2)	Import Drug Application	2024-02-24	Bristol-Myers Squibb Pharma Eeig;Bristol-Myers Squibb Holdings Pharma Ltd Liability Company;BRISTOL-MYERS Squibb (CHINA) Co Ltd	view
JXSS2400014	纳武利尤单抗注射液	nivolumab	Injection	Biological Products(2.2)	Import Drug Application	2024-02-24	Bristol-Myers Squibb Pharma Eeig;Bristol-Myers Squibb Holdings Pharma Ltd Liability Company;BRISTOL-MYERS Squibb (CHINA) Co Ltd	view
JYSB2300219	纳武利尤单抗注射液	nivolumab	Injection	Biological Products	Supplementary Application	2023-12-20	Bristol-Myers Squibb Pharma Eeig;Bristol-Myers Squibb Holdings Pharma Ltd Liability Company	view
JYSB2300218	纳武利尤单抗注射液	nivolumab	Injection	Biological Products	Supplementary Application	2023-12-20	Bristol-Myers Squibb Pharma Eeig;Bristol-Myers Squibb Holdings Pharma Ltd Liability Company	view
JYSB2300210	纳武利尤单抗注射液	nivolumab	Injection	Biological Products	Supplementary Application	2023-12-09	Bristol-Myers Squibb Pharma Eeig;Bristol-Myers Squibb Holdings Pharma Ltd Liability Company	view
JYSB2300209	纳武利尤单抗注射液	nivolumab	Injection	Biological Products	Supplementary Application	2023-12-09	Bristol-Myers Squibb Pharma Eeig;Bristol-Myers Squibb Holdings Pharma Ltd Liability Company	view
JXSB2300139	纳武利尤单抗注射液	nivolumab	Injection	Biological Products	Supplementary Application	2023-11-30	Bristol-Myers Squibb Holdings Pharma Ltd Liability Company;Bristol-Myers Squibb Company	view
JYSB2300067	纳武利尤单抗注射液	nivolumab	Injection	Biological Products	Supplementary Application	2023-04-19	Vetter Pharma-Fertigung Gmbh & Co KG;Bristol-Myers Squibb Pharma Eeig	view
JYSZ2200059	纳武利尤单抗注射液	nivolumab	Injection	Biological Products	License Renew	2022-11-04	Bristol-Myers Squibb Pharma Eeig;Bristol-Myers Squibb Holdings Pharma Ltd Liability Company;BRISTOL-MYERS Squibb (CHINA) Co Ltd	view
JYSZ2200060	纳武利尤单抗注射液	nivolumab	Injection	Biological Products	License Renew	2022-11-04	Bristol-Myers Squibb Pharma Eeig;Bristol-Myers Squibb Holdings Pharma Ltd Liability Company;BRISTOL-MYERS Squibb (CHINA) Co Ltd	view
JXSL2200055	纳武利尤单抗注射液	nivolumab	Injection	Biological Products(2.2)	Import Drug Application	2022-05-07	Bristol-Myers Squibb Company;BRISTOL-MYERS Squibb (CHINA) Co Ltd	view
JYSB2200075	纳武利尤单抗注射液	nivolumab	Injection	Biological Products	Supplementary Application	2022-04-24	Bristol-Myers Squibb Pharma Eeig;Bristol-Myers Squibb Holdings Pharma Ltd Liability Company	view